Inhibitor of H3K27 demethylase JMJD3/UTX GSK-J4 is a potential therapeutic option for castration resistant prostate cancer.
about
Inhibitor of H3K27 demethylase JMJD3/UTX GSK-J4 is a potential therapeutic option for castration resistant prostate cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Inhibitor of H3K27 demethylase ...... ion resistant prostate cancer.
@en
type
label
Inhibitor of H3K27 demethylase ...... ion resistant prostate cancer.
@en
prefLabel
Inhibitor of H3K27 demethylase ...... ion resistant prostate cancer.
@en
P2093
P2860
P356
P1433
P1476
Inhibitor of H3K27 demethylase ...... ion resistant prostate cancer.
@en
P2093
Alexander M Ishov
Matthew M Clowers
Viacheslav M Morozov
P2860
P304
62131-62142
P356
10.18632/ONCOTARGET.19100
P407
P577
2017-07-08T00:00:00Z